These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [On the effectiveness of rifampicin and ethambutol used in 3 different therapeutical schemes in drug-resistant chronic pulmonary tuberculosis]. Andrian A, Ciobanu V, Cojocaru G, Borşaru I, Ciobanu D, Spirescu G, Roşianu D, Pescariu M. Ftiziologia; 1971 Feb; 20(6):623-8. PubMed ID: 5162289 [No Abstract] [Full Text] [Related]
10. [Early results of treatment of chronic pulmonary tuberculosis with rifampicin and ethambutol adminstered intermittently once or twice a week preceded by a 3-month continuous administration]. Kost A, Moskwa Z. Gruzlica; 1975 Aug; 43(8):719-26. PubMed ID: 1158177 [No Abstract] [Full Text] [Related]
12. [Late results of treatment of chronic pulmonary tuberculosis with rifampicin]. Lachowicz E, Polaczek E, Araszkiewicz W, Kozakow H, Pszonicka A, Styszewska H, Janowiec M, Grabowska R. Gruzlica; 1973 Jul; 41(7):781-7. PubMed ID: 4730979 [No Abstract] [Full Text] [Related]
13. [Rifampicin combined with ethambutol and other antitubercular agents in the treatment of patients with chronic pulmonary tuberculosis. Early results. II. Analysis of causes of treatment interruption]. Masztalerz J. Pneumonol Pol; 1976 Feb; 44(2):153-61. PubMed ID: 940788 [No Abstract] [Full Text] [Related]
15. [Controlled trial of isoniazid.rifampicin.ethambutol regimen and isoniazid.rifampicin.pyrazinamide regimen in the primary chemotherapy for pulmonary tuberculosis (author's transl)]. Kekkaku; 1980 Jan; 55(1):7-13. PubMed ID: 6988627 [No Abstract] [Full Text] [Related]
16. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis]. Saito W, Nagayama N, Miyamoto M, Hara H, Suzuki J, Masuda K, Baba M, Tamura A, Nagai H, Akagawa S, Kawabe Y, Machida K, Kurashima A, Yotsumoto H. Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568 [Abstract] [Full Text] [Related]